ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 324,41
0,43%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) Actualités

BNTX

BioNTech (BNTX)

BioNTech SE
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DateHeureSourceTitreSymboleSociété
10/03/202512h00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:BNTXBioNTech SE
10/03/202511h57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
10/03/202511h55GlobeNewswire Inc.BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
27/02/202513h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
24/02/202512h45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025NASDAQ:BNTXBioNTech SE
04/02/202517h15IH Market NewsModerna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s NominationNASDAQ:BNTXBioNTech SE
03/02/202512h45GlobeNewswire Inc.BioNTech Completes Acquisition of BiotheusNASDAQ:BNTXBioNTech SE
14/01/202512h45GlobeNewswire Inc.BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BNTXBioNTech SE
13/11/202423h00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BNTXBioNTech SE
13/11/202412h45GlobeNewswire Inc.BioNTech to Acquire Biotheus to Boost Oncology StrategyNASDAQ:BNTXBioNTech SE
04/11/202412h45GlobeNewswire Inc.BioNTech Announces Third Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/10/202412h45GlobeNewswire Inc.BioNTech to Host Innovation Series R&D Day on November 14, 2024NASDAQ:BNTXBioNTech SE
21/10/202412h45GlobeNewswire Inc.BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024NASDAQ:BNTXBioNTech SE
01/10/202412h00GlobeNewswire Inc.BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI DayNASDAQ:BNTXBioNTech SE
20/09/202414h11Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European UnionNASDAQ:BNTXBioNTech SE
17/09/202412h45GlobeNewswire Inc.BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024NASDAQ:BNTXBioNTech SE
05/09/202413h15GlobeNewswire Inc.BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024NASDAQ:BNTXBioNTech SE
22/08/202420h15Business WirePfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineNASDAQ:BNTXBioNTech SE
16/08/202412h45Business WirePfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of AgeNASDAQ:BNTXBioNTech SE
05/08/202411h59GlobeNewswire Inc.BioNTech Announces Second Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/07/202411h55IH Market NewsASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and MoreNASDAQ:BNTXBioNTech SE
30/07/202412h45GlobeNewswire Inc.BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced MelanomaNASDAQ:BNTXBioNTech SE
22/07/202412h45GlobeNewswire Inc.BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024NASDAQ:BNTXBioNTech SE
27/06/202416h30Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European UnionNASDAQ:BNTXBioNTech SE
27/06/202416h30GlobeNewswire Inc.Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union  NASDAQ:BNTXBioNTech SE
24/06/202412h45GlobeNewswire Inc.BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate CancerNASDAQ:BNTXBioNTech SE
01/06/202416h00GlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
29/05/202414h00GlobeNewswire Inc.BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine EcosystemNASDAQ:BNTXBioNTech SE
27/05/202402h00PR Newswire (US)MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnershipNASDAQ:BNTXBioNTech SE
21/05/202412h45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024NASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX

Dernières Valeurs Consultées

USOTC
TONR
Tonner One World (PK)
BIT
UC7V2V
Unicredit Bank
BIT
UC6Y5K
Unicredit Bank
BIT
NSCIT8879032
Credit Institute for Rec...
COIN
FEXBTC
FidexToken
BIT
UC4VD0
Unicredit Bank
BIT
NSCIT8052606
EIB European Investment ...
BIT
UC4KSR
Unicredit Bank
NYSE
NVRO
Nevro
NASDAQ
CSCO
Cisco Systems
BIT
UB593A
Unicredit Bank
NASDAQ
AUUDW
Auddia
BIT
UI666C
Unicredit Bank
USOTC
TETAA
Teton Advisors (QX)
USOTC
YUEIY
Yue Yuen Industrial (PK)
USOTC
AMLTF
AMP (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces